Obesity News

A new study in the Journal of Osteopathic Medicine showed that higher BMIs before pregnancy correlated with increasing risks for maternal and neonatal morbidity.

Dispensing of GLP-1 receptor agonists increased nearly 600% among adolescents and young adults in the United States from 2020 to 2023 and was particularly significant among girls and young women, a new study showed.

A once-weekly basal insulin provided noninferior HbA1c reductions compared with once-daily insulins in adults with type 2 diabetes who had never taken insulin as well as those who received multiple daily insulin injections, phase 3 data show.

Adults with diabetes who used a GLP-1 receptor agonist and underwent surgery requiring general anesthesia had similar odds for postsurgical complications as those receiving other oral diabetes medications, according to study data.

Last month, the Obesity Medicine Association held its annual conference, where clinicians across the country came together to discuss the latest developments in obesity care.

Individuals prescribed the antidiabetes treatment metformin less likely developed a myeloproliferative neoplasm —potentially also reducing a person’s chances for developing certain cancers — according to data published in Blood Advances.

In patients with type 2 diabetes who underwent ablation for atrial fibrillation, those taking a GLP-1 receptor agonist had lower risk for AF recurrence, mortality and other outcomes, researchers reported at Heart Rhythm 2024.

A noninvasive sensor may measure glucose values by using dielectric spectroscopy to scan radiofrequencies, according to a speaker at the American Association of Clinical Endocrinology Annual Meeting.

In patients with the obesity phenotype of HF with preserved ejection, semaglutide 2.4 mg improved HF-related symptoms and physical limitations vs. placebo regardless of diuretic use, according to new data from the STEP-HFpEF trials.

BOSTON — In this video, Healio Primary Care Peer Perspective Board Member Alan Dow, MD, MSHA, FACP, highlights important takeaways from the ACP Internal Medicine Meeting.